# Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects

> **NCT00852956** · PHASE1 · COMPLETED · sponsor: **OBEcure Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Betahistine

## Key facts

- **NCT ID:** NCT00852956
- **Lead sponsor:** OBEcure Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852956, "Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00852956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*